Clinical Drug Experience Knowledgebase

anastrozole (arimidex) (1 trial)

everolimus (zortress) (1 trial)

exemestane (aromasin) (2 trials)

fulvestrant (faslodex) (2 trials)

letrozole (femara) (1 trial)

atezolizumab (Tecentriq) (1 trial)

avelumab (bavencio) (1 trial)

axitinib (inlyta) (1 trial)

bevacizumab (avastin) (1 trial)

binimetinib (mektovi) (1 trial)

carboplatin (paraplatin) (1 trial)

cisplatin (platinol) (1 trial)

cobimetinib (cotellic) (1 trial)

encorafenib (braftovi) (1 trial)

eribulin (halaven) (1 trial)

gemcitabine (gemzar) (1 trial)

ipilimumab (yervoy) (2 trials)

lapatinib (tykerb) (1 trial)

lorlatinib (lorbrena) (1 trial)

nivolumab (opdivo) (2 trials)

rutin (1 trial)

sunitinib (sutent) (1 trial)

trastuzumab (herceptin) (1 trial)

vemurafenib (zelboraf) (1 trial)